| RS2487359618 |
PLPBP
|
Health Risk |
Pathogenic |
— |
| RS2487371953 |
PLPBP
|
Health Risk |
Pathogenic |
— |
| RS2487372007 |
PLPBP
|
Health Risk |
Pathogenic |
— |
| RS2487372034 |
PLPBP
|
Health Risk |
Likely pathogenic |
— |
| RS2487374176 |
ANK1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spherocytosis type 1, Hereditary spherocytosis type 1 |
| RS2487450103 |
PEX2
|
Health Risk |
Likely pathogenic |
Peroxisome biogenesis disorder 5A (Zellweger), Peroxisome biogenesis disorder 5A (Zellweger) |
| RS2487450260 |
PEX2
|
Health Risk |
Likely pathogenic |
Peroxisome biogenesis disorder 5A (Zellweger), Peroxisome biogenesis disorder 5A (Zellweger) |
| RS2487451078 |
PEX2
|
Health Risk |
Likely pathogenic |
Peroxisome biogenesis disorder 5A (Zellweger), Peroxisome biogenesis disorder 5A (Zellweger) |
| RS2487451205 |
PEX2
|
Health Risk |
Pathogenic/Likely pathogenic |
Peroxisome biogenesis disorder 5A (Zellweger), Peroxisome biogenesis disorder 5A (Zellweger) |
| RS2487451515 |
PEX2
|
Health Risk |
Likely pathogenic |
Peroxisome biogenesis disorder 5A (Zellweger), Peroxisome biogenesis disorder 5A (Zellweger) |
| RS2487451611 |
PEX2
|
Health Risk |
Likely pathogenic |
Peroxisome biogenesis disorder 5A (Zellweger), Peroxisome biogenesis disorder 5B |
| RS2487451701 |
PEX2
|
Health Risk |
Pathogenic/Likely pathogenic |
Peroxisome biogenesis disorder 5A (Zellweger), Peroxisome biogenesis disorder 5A (Zellweger) |
| RS2487451984 |
PEX2
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 5A (Zellweger), Peroxisome biogenesis disorder 5A (Zellweger) |
| RS2487452030 |
PEX2
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 5A (Zellweger), Peroxisome biogenesis disorder 5A (Zellweger) |
| RS2487452268 |
PEX2
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 5A (Zellweger), Peroxisome biogenesis disorder 5A (Zellweger) |
| RS2487452374 |
PEX2
|
Health Risk |
Likely pathogenic |
Peroxisome biogenesis disorder 5A (Zellweger), Peroxisome biogenesis disorder 5A (Zellweger) |
| RS2487452618 |
PEX2
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 5A (Zellweger), Peroxisome biogenesis disorder 5A (Zellweger) |
| RS2487452658 |
PEX2
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 5A (Zellweger), Peroxisome biogenesis disorder 5A (Zellweger) |
| RS2487452856 |
PEX2
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 5A (Zellweger), Peroxisome biogenesis disorder 5A (Zellweger) |
| RS2487452894 |
PEX2
|
Health Risk |
Likely pathogenic |
Peroxisome biogenesis disorder 5A (Zellweger), Peroxisome biogenesis disorder 5A (Zellweger) |
| RS2487452936 |
PEX2
|
Health Risk |
Likely pathogenic |
Peroxisome biogenesis disorder 5A (Zellweger), Peroxisome biogenesis disorder 5A (Zellweger) |
| RS2487453237 |
PEX2
|
Health Risk |
Likely pathogenic |
Peroxisome biogenesis disorder 5A (Zellweger), Peroxisome biogenesis disorder 5A (Zellweger) |
| RS2487453279 |
PEX2
|
Health Risk |
Likely pathogenic |
Peroxisome biogenesis disorder 5A (Zellweger), Peroxisome biogenesis disorder 5A (Zellweger) |
| RS2487453331 |
PEX2
|
Health Risk |
Pathogenic/Likely pathogenic |
Peroxisome biogenesis disorder 5A (Zellweger), Peroxisome biogenesis disorder 5B |
| RS2487453569 |
PEX2
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 5A (Zellweger), Peroxisome biogenesis disorder 5A (Zellweger) |
| RS2487453776 |
PEX2
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder, Peroxisome biogenesis disorder |
| RS2487454016 |
PEX2
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 5A (Zellweger), Peroxisome biogenesis disorder 5A (Zellweger) |
| RS2487454145 |
PEX2
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 5A (Zellweger), Peroxisome biogenesis disorder 5A (Zellweger) |
| RS2487481768 |
PMP2
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease, demyelinating |
| RS2487491252 |
SLC20A2
|
Health Risk |
Likely pathogenic |
Idiopathic basal ganglia calcification 1, Idiopathic basal ganglia calcification 1 |
| RS2487503753 |
IKBKB
|
Health Risk |
Likely pathogenic |
— |
| RS2487524655 |
SLC20A2
|
Health Risk |
Pathogenic |
— |
| RS2487536492 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS2487538167 |
ANK1
|
Health Risk |
Pathogenic |
Hereditary spherocytosis type 1, Hereditary spherocytosis type 1 |
| RS2487538961 |
CHD7
|
Health Risk |
Pathogenic |
Hypogonadotropic hypogonadism 5 with or without anosmia, Hypogonadotropic hypogonadism 5 with or without anosmia |
| RS2487539517 |
ANK1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spherocytosis type 1, Hereditary spherocytosis type 1 |
| RS2487540941 |
CHD7
|
Health Risk |
Pathogenic |
CHD7-related disorder, CHD7-related disorder |
| RS2487541533 |
CHD7
|
Health Risk |
Pathogenic |
— |
| RS2487561526 |
ANK1
|
Health Risk |
Pathogenic |
— |
| RS2487561666 |
ANK1
|
Health Risk |
Likely pathogenic |
— |
| RS2487562970 |
SYNE1
|
Health Risk |
Likely pathogenic |
Autosomal recessive ataxia, Beauce type |
| RS2487573703 |
KMT2C
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2487587513 |
KMT2C
|
Health Risk |
Pathogenic |
Kleefstra syndrome 2, Kleefstra syndrome 2 |
| RS2487596421 |
KMT2C
|
Health Risk |
Likely pathogenic |
Kleefstra syndrome 2, Kleefstra syndrome 2 |
| RS2487601133 |
KMT2C
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, Intellectual disability |
| RS2487605072 |
ANK1
|
Health Risk |
Likely pathogenic |
Hereditary spherocytosis type 1, Hereditary spherocytosis type 1 |
| RS2487605572 |
ANK1
|
Health Risk |
Likely pathogenic |
Hereditary spherocytosis type 1, Hereditary spherocytosis type 1 |
| RS2487605887 |
ANK1
|
Health Risk |
Pathogenic |
Hereditary spherocytosis type 1, Hereditary spherocytosis type 1 |
| RS2487606030 |
ANK1
|
Health Risk |
Pathogenic |
— |
| RS2487606714 |
ANK1
|
Health Risk |
Likely pathogenic |
— |
| RS2487606977 |
ANK1
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS2487607030 |
ANK1
|
Health Risk |
Pathogenic |
Hereditary spherocytosis type 1, Hereditary spherocytosis type 1 |
| RS2487607275 |
ANK1
|
Health Risk |
Likely pathogenic |
Hereditary spherocytosis type 1, Hereditary spherocytosis type 1 |
| RS2487614684 |
KMT2C
|
Health Risk |
Likely pathogenic |
Kleefstra syndrome 2, Kleefstra syndrome 2 |
| RS2487614749 |
KMT2C
|
Health Risk |
Likely pathogenic |
Kleefstra syndrome 2, Kleefstra syndrome 2 |
| RS2487624106 |
SLC20A2
|
Health Risk |
Pathogenic |
Idiopathic basal ganglia calcification 1, Idiopathic basal ganglia calcification 1 |
| RS2487626033 |
SLC20A2
|
Health Risk |
Pathogenic |
Idiopathic basal ganglia calcification 1, Idiopathic basal ganglia calcification 1 |
| RS2487634896 |
ANK1
|
Health Risk |
Likely pathogenic |
Hereditary spherocytosis type 1, Hereditary spherocytosis type 1 |
| RS2487634907 |
ANK1
|
Health Risk |
Likely pathogenic |
Hereditary spherocytosis type 1, Hereditary spherocytosis type 1 |
| RS2487635140 |
ANK1
|
Health Risk |
Likely pathogenic |
Hereditary spherocytosis type 1, Hereditary spherocytosis type 1 |
| RS2487635203 |
ANK1
|
Health Risk |
Pathogenic |
Hereditary spherocytosis type 1, Hereditary spherocytosis type 1 |
| RS2487635534 |
ANK1
|
Health Risk |
Pathogenic |
Hereditary spherocytosis type 1, ANK1-related disorder |
| RS2487635655 |
CHD7
|
Health Risk |
Likely pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS2487635721 |
ANK1
|
Health Risk |
Likely pathogenic |
Hereditary spherocytosis type 1, Hereditary spherocytosis type 1 |
| RS2487636080 |
ANK1
|
Health Risk |
Likely pathogenic |
— |
| RS2487636997 |
ANK1
|
Health Risk |
Likely pathogenic |
Hereditary spherocytosis type 1, Hereditary spherocytosis type 1 |
| RS2487637471 |
ANK1
|
Health Risk |
Likely pathogenic |
Hereditary spherocytosis type 1, Hereditary spherocytosis type 1 |
| RS2487637859 |
ANK1
|
Health Risk |
Likely pathogenic |
— |
| RS2487637881 |
ANK1
|
Health Risk |
Pathogenic |
Hereditary spherocytosis type 1, Hereditary spherocytosis type 1 |
| RS2487638186 |
ANK1
|
Health Risk |
Pathogenic |
— |
| RS2487638198 |
ANK1
|
Health Risk |
Likely pathogenic |
— |
| RS2487638331 |
ANK1
|
Health Risk |
Likely pathogenic |
Hereditary spherocytosis type 1, Hereditary spherocytosis type 1 |
| RS2487638391 |
ANK1
|
Health Risk |
Likely pathogenic |
Hereditary spherocytosis type 1, Hereditary spherocytosis type 1 |
| RS2487638564 |
ANK1
|
Health Risk |
Pathogenic |
— |
| RS2487638615 |
ANK1
|
Health Risk |
Pathogenic |
— |
| RS2487640420 |
ANK1
|
Health Risk |
Likely pathogenic |
Hereditary spherocytosis type 1, Hereditary spherocytosis type 1 |
| RS2487640614 |
ANK1
|
Health Risk |
Likely pathogenic |
— |
| RS2487645340 |
IKBKB
|
Health Risk |
Likely pathogenic |
Severe combined immunodeficiency due to IKK2 deficiency, Severe combined immunodeficiency due to IKK2 deficiency |
| RS2487672040 |
CHD7
|
Health Risk |
Conflicting classifications of pathogenicity |
CHARGE syndrome, CHARGE syndrome |
| RS2487673689 |
CHD7
|
Health Risk |
Likely pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS2487679210 |
IKBKB
|
Health Risk |
Likely pathogenic |
IKBKB-related disorder, IKBKB-related disorder |
| RS2487680645 |
IKBKB
|
Health Risk |
Conflicting classifications of pathogenicity |
Severe combined immunodeficiency due to IKK2 deficiency, Immunodeficiency 15a |
| RS2487681869 |
CHD7
|
Health Risk |
Likely pathogenic |
— |
| RS2487681882 |
CHD7
|
Health Risk |
Likely pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS2487684661 |
KMT2C
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2487684914 |
KMT2C
|
Health Risk |
Likely pathogenic |
Kleefstra syndrome 2, Kleefstra syndrome 2 |
| RS2487689029 |
KMT2C
|
Health Risk |
Pathogenic/Likely pathogenic |
Kleefstra syndrome 2, KMT2C-related NDD |
| RS2487691137 |
KMT2C
|
Health Risk |
Likely pathogenic |
Kleefstra syndrome 2, Kleefstra syndrome 2 |
| RS2487691264 |
KMT2C
|
Health Risk |
Pathogenic |
Kleefstra syndrome 2, Kleefstra syndrome 2 |
| RS2487691864 |
IKBKB
|
Health Risk |
Likely pathogenic |
Severe combined immunodeficiency due to IKK2 deficiency, Severe combined immunodeficiency due to IKK2 deficiency |
| RS2487692827 |
IKBKB
|
Health Risk |
Pathogenic |
Severe combined immunodeficiency due to IKK2 deficiency, Severe combined immunodeficiency due to IKK2 deficiency |
| RS2487693202 |
KMT2C
|
Health Risk |
Likely pathogenic |
— |
| RS2487713743 |
IKBKB
|
Health Risk |
Pathogenic |
Severe combined immunodeficiency due to IKK2 deficiency, Severe combined immunodeficiency due to IKK2 deficiency |
| RS2487731363 |
IKBKB
|
Health Risk |
Pathogenic |
Severe combined immunodeficiency due to IKK2 deficiency, Severe combined immunodeficiency due to IKK2 deficiency |
| RS2487734648 |
IKBKB
|
Health Risk |
Pathogenic |
Severe combined immunodeficiency due to IKK2 deficiency, Severe combined immunodeficiency due to IKK2 deficiency |
| RS2487739397 |
IKBKB
|
Health Risk |
Pathogenic |
Severe combined immunodeficiency due to IKK2 deficiency, Severe combined immunodeficiency due to IKK2 deficiency |
| RS2487767059 |
KMT2C
|
Health Risk |
Pathogenic |
— |
| RS2487773907 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS2487774289 |
CHD7
|
Health Risk |
Likely pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS2487774322 |
CHD7
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |